Predict your next investment

Corporation
HEALTHCARE | Drug Delivery
valeritas.com

See what CB Insights has to offer

Executives

9

Board of Directors

9

Valeritas Board of Directors

9 Board of directors

Valeritas has 9 board of directors, including Brian Roberts.

Name

Firm

Work History

Other Seats

Brian Roberts

CFO, Avedro Inc.; CFO, Jingle Networks; CFO, Digitas; VP, Finance, Idiom Technologies; Senior Auditor, Ernst & Young

ViewRay

Daniel Pelak

Mr. Pelak is a senior advisor with Welsh, Carson, Anderson & Stowe (WCAS), focusing on investments in the healthcare industry. Prior to joining WCAS, Mr. Pelak was the chief executive officer at InnerPulse, a privately held, early-stage cardiac medical device company. Prior to joining InnerPulse, he was the CEO of Closure Medical Corporation, a publically traded biomaterial-based medical adhesive company, until its acquisition by Johnson & Johnson in 2005. Mr. Pelak began his industry career at Medtronic, where he spent over 20 years. His executive assignments at Medtronic included vice president of U.S. Marketing, and worldwide responsibility for three different operating divisions as vice president and general manager.

Mardil Medical, Oncoscope, and Vertos Medical

John Barr

President & CEO, V I Technologies; President, North American Operations, Haemonetics; Executive, Baxter Healthcare

Apollo Endosurgery, and EarlySense

John Ryan

John Ryan joined ONSET Ventures in 2008 and specializes in investment opportunities in the medical technology sector. He has beeninvolved, throughout his career with the founding, building, and financing of companies across many sectors of the healthcare industryat stages ranging from the earliest company formation to the largest industry leaders.Prior to ONSET, John led the venture investing efforts in the medical device sector for Panorama Capital, JPMorgan Partners, and ChaseCapital Partners. During that time, John led investments in and served on the board of directors of companies such as CardioKinetix, FlowCardia, Innovative Spinal Technologies, Novasys Medical, and PowerVision. Prior to that, John worked with Morgan Stanley Venture Partners where he participated in investments in companies such as Intuitive Surgical (NASDAQ: ISRG), R2 Technologies (acquired by Hologic), and Rita Medical Systems (acquired by AngioDynamics). Earlier, John worked with Morgan Stanley's investment banking group as part of a team that was a leader in M&A

Health Market Science, and Vertos Medical

Sean Traynor

Mr. Traynor is a member of the Management Committee, having joined WCAS in 1999. He focuses on investments in the healthcare industry. Prior to joining WCAS, he worked in the healthcare and insurance investment banking groups at BT Alex. Brown. Mr. Traynor spent three years with Coopers & Lybrand. He earned a bachelor's degree from Villanova University in 1991 and an M.B.A. from the Wharton School of Business in 1996.

naviHealth, and Universal American Corp.

Name

Brian Roberts

Daniel Pelak

John Barr

John Ryan

Sean Traynor

Firm

Work History

CFO, Avedro Inc.; CFO, Jingle Networks; CFO, Digitas; VP, Finance, Idiom Technologies; Senior Auditor, Ernst & Young

Mr. Pelak is a senior advisor with Welsh, Carson, Anderson & Stowe (WCAS), focusing on investments in the healthcare industry. Prior to joining WCAS, Mr. Pelak was the chief executive officer at InnerPulse, a privately held, early-stage cardiac medical device company. Prior to joining InnerPulse, he was the CEO of Closure Medical Corporation, a publically traded biomaterial-based medical adhesive company, until its acquisition by Johnson & Johnson in 2005. Mr. Pelak began his industry career at Medtronic, where he spent over 20 years. His executive assignments at Medtronic included vice president of U.S. Marketing, and worldwide responsibility for three different operating divisions as vice president and general manager.

President & CEO, V I Technologies; President, North American Operations, Haemonetics; Executive, Baxter Healthcare

John Ryan joined ONSET Ventures in 2008 and specializes in investment opportunities in the medical technology sector. He has beeninvolved, throughout his career with the founding, building, and financing of companies across many sectors of the healthcare industryat stages ranging from the earliest company formation to the largest industry leaders.Prior to ONSET, John led the venture investing efforts in the medical device sector for Panorama Capital, JPMorgan Partners, and ChaseCapital Partners. During that time, John led investments in and served on the board of directors of companies such as CardioKinetix, FlowCardia, Innovative Spinal Technologies, Novasys Medical, and PowerVision. Prior to that, John worked with Morgan Stanley Venture Partners where he participated in investments in companies such as Intuitive Surgical (NASDAQ: ISRG), R2 Technologies (acquired by Hologic), and Rita Medical Systems (acquired by AngioDynamics). Earlier, John worked with Morgan Stanley's investment banking group as part of a team that was a leader in M&A

Mr. Traynor is a member of the Management Committee, having joined WCAS in 1999. He focuses on investments in the healthcare industry. Prior to joining WCAS, he worked in the healthcare and insurance investment banking groups at BT Alex. Brown. Mr. Traynor spent three years with Coopers & Lybrand. He earned a bachelor's degree from Villanova University in 1991 and an M.B.A. from the Wharton School of Business in 1996.

Other Seats

ViewRay

Mardil Medical, Oncoscope, and Vertos Medical

Apollo Endosurgery, and EarlySense

Health Market Science, and Vertos Medical

naviHealth, and Universal American Corp.

Valeritas Management Team

9 Team Members

Valeritas has 9 executives. Valeritas's current Chief Executive Officer, President is John E Timberlake.

Name

Work History

Title

Status

John E Timberlake

Chief Executive Officer, President

Current

Erick J Lucera

Chief Financial Officer

Current

Matthew Nguyen

Chief Commercial Officer

Current

Geoffrey Jenkins

Executive Vice President

Current

James E Dentzer

Chief Financial Officer

Former

Name

John E Timberlake

Erick J Lucera

Matthew Nguyen

Geoffrey Jenkins

James E Dentzer

Work History

Title

Chief Executive Officer, President

Chief Financial Officer

Chief Commercial Officer

Executive Vice President

Chief Financial Officer

Status

Current

Current

Current

Current

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.